Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis
Journal of Diabetes Investigation · 2026
DOI: 10.1111/jdi.70398 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2026. Verfasst von Kun Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Operating Room, Shaanxi Provincial People's Hospital, Xi'an, China. Hauptthemen laut MEDLINE: Liraglutide, Muscle, Smooth, Vascular, Atherosclerosis, Extracellular Matrix. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Innovation Team Project of Shaanxi Provincial Department of Science and Technology, Traditional Chinese Medicine Scientific Research and Innovation Talent Project of Shaanxi Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
Background
Metabolic reprogramming contributes to vascular dysfunction in diabetic atherosclerosis, but the mechanisms linking hyperglycemia‐induced metabolic alterations to extracellular matrix remodeling in vascular smooth muscle cells remain incompletely understood. This study investigated whether liraglutide modulates vascular smooth muscle cell metabolism and plaque remodeling under diabetic conditions.
Methods
Primary vascular smooth muscle cells were exposed to normal glucose, high glucose, or high glucose plus liraglutide. Cellular bioenergetics, mitochondrial function, oxidative stress, extracellular matrix remodeling, and AMPK/PGC‐1α, mTOR, and HIF‐1α signaling were assessed. In vivo , diabetic ApoE −/− mice were treated with liraglutide for 12 weeks, followed by evaluation of metabolic parameters, aortic root plaque burden, lipid deposition, collagen content, and plaque‐associated signaling markers.
Results
High glucose impaired mitochondrial respiration, enhanced glycolysis, reduced mitochondrial membrane potential, increased mitochondrial reactive oxygen species, and promoted mitochondrial fragmentation and extracellular matrix remodeling in vascular smooth muscle cells. Liraglutide restored mitochondrial function, activated AMPK/PGC‐1α signaling, suppressed mTOR activation and HIF‐1α accumulation, reduced collagen I, MMP‐2, and MMP‐9 expression, and partially restored elastin levels. In diabetic ApoE −/− mice, liraglutide improved systemic metabolic parameters, reduced atherosclerotic plaque burden and lipid accumulation, increased plaque collagen content, restored plaque p‐AMPK expression, and reduced HIF‐1α and MMP‐9 expression.
Conclusions
Liraglutide attenuates hyperglycemia‐induced metabolic reprogramming and extracellular matrix remodeling in vascular smooth muscle cells and improves plaque stability in diabetic atherosclerosis. These effects are associated with restoration of AMPK/PGC‐1α signaling, inhibition of mTOR activation, suppression of HIF‐1α accumulation, and improved mitochondrial homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Operating Room, Shaanxi Provincial People's Hospital, Xi'an, China.
- School of Medicine, Yan'an University, Yan'an, China.
- Department of Cardiology, Shaanxi Provincial People's Hospital, Xi'an, China.
- Department of Cardiovascular Surgery, Shaanxi Provincial People's Hospital, Xi'an, China.
- Shaanxi Cardiovascular and Cerebrovascular Disease Precision Medicine "Belt and Road" Joint Laboratory, Xi'an, China.
- School of Life Sciences and Technology, Northwestern Polytechnical University, Xi'an, China.
ORCID-Profile: Zhongwei Liu
Förderung
- Science and Technology Innovation Team Project of Shaanxi Provincial Department of Science and Technology
- Traditional Chinese Medicine Scientific Research and Innovation Talent Project of Shaanxi Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Zhu, K., Liu, H., He, N., Wang, H., Liu, J., Zhang, Q., & Liu, Z. (2026). Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70398
Vancouver
Zhu K, Liu H, He N, Wang H, Liu J, Zhang Q, et al. Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis. Journal of Diabetes Investigation. 2026. doi:10.1111/jdi.70398
BibTeX
@article{Zhu2026,
author = {Zhu, Kun and Liu, Hanxiu and He, Ni and Wang, Haoyang and Liu, Jing and Zhang, Qinhu and Liu, Zhongwei},
title = {Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis},
journal = {Journal of Diabetes Investigation},
year = {2026},
doi = {10.1111/jdi.70398}
}
EUVIMED